Effectiveness of Subcutaneous Casirivimab and Imdevimab in Ambulatory Patients with COVID-19.
Jalbert JJ, Hussein M, Mastey V, Sanchez RJ, Wang D, Murdock D, Fariñas L, Bussey J, Duart C, Hirshberg B, Weinreich DM, Wei W.
Jalbert JJ, et al.
Infect Dis Ther. 2022 Dec;11(6):2125-2139. doi: 10.1007/s40121-022-00691-z. Epub 2022 Oct 1.
Infect Dis Ther. 2022.
PMID: 36181639
Free PMC article.